Ypsomed
Biljana Gampp is a seasoned professional in quality assurance and regulatory affairs, currently serving as Manager Quality Assurance at Ypsomed AG since December 2022. Prior to this role, Gampp held the position of Head of Regulatory Affairs at GEMÜ GmbH from January 2021 to November 2022, where responsibilities included the development and implementation of regulatory strategies for bio, food, pharma, medical devices, and in-vitro diagnostics. Gampp's extensive experience at GEMÜ GmbH from December 2011 to January 2021 encompassed regulatory affairs management, quality management, and project leadership in quality management systems. Earlier roles at WEIDMANN PLASTICS and SCHURTER AG involved quality management, product audits, employee training, and process measurement, further showcasing a strong background in quality assurance and compliance.
This person is not in the org chart
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.